Brief: Cellect Biotechnology Receives Approval For U.S. Clinical Trial

Quoin Pharmaceuticals

23/12/2019 12:17

Dec 23 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY RECEIVES APPROVAL FOR U.S. CLINICAL
TRIAL
    * CELLECT - GOT APPROVAL TO BEGIN TRIAL IN U.S. TO EVALUATE
SAFETY, TOLERABILITY OF APOGRAFT TECHNOLOGY FOR HAPLOIDENTICAL
BONE MARROW TRANSPLANTATIONS

Source text for Eikon:  ID:nPn6xW08la 
Further company coverage:  APOP.O 

 (Reuters.Briefs@thomsonreuters.com)